Logo-aim
Arch Iran Med. 2022;25(5): 329-338. doi: 10.34172/aim.2022.54

Review

Major Depressive Disorder in Iran: Epidemiology, Health Care Provision, Utilization, and Challenges

Masoumeh Amin-Esmaeili 1,2 ORCID, Behrang Shadloo 1 ORCID, Afarin Rahimi-Movaghar 1 * ORCID, Seyed Mehdi Samimi Ardestani 3 ORCID, Ahmad Hajebi 4 ORCID, Shahab Khatibzadeh 5, Vandad Sharifi 6, Roya Samadi 7, Mohammad Taghi Yasamy 8 ORCID, Mehran Zarghami 9 ORCID, Farshad Farzadfar 10 ORCID, Saeid Shahraz 5,11

Cited by CrossRef: 3


1- Ma J, Zhou H, Fu Q, Lu G. Facilitators and barriers in the development and implementation of depression prevention and treatment policies in China: a qualitative study. BMC Public Health. 2023;23(1) [Crossref]
2- Nasirpour N, Esmailzadehha N, Hajebi A, Savari E, Ghanbari B, Motevalian A. Preexisting depression and COVID-19: a cohort study on the risk of susceptibility and hospitalization. BMC Psychiatry. 2023;23(1) [Crossref]


SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.